TrialCancer medicine2022

What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study.

Sara Pizzamiglio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.